Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Abcam AS601245 JNK Inhibitor, Selective, ATP Competitive, Solid, 25 mg

Catalog No. 502705410
Encompass_Preferred
Change view
Click to view available options
Quantity:
25 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-270-5410 25 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-270-5410 Supplier Abcam Supplier No. AB14519425MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Potent and selective ATP-competitive JNK inhibitor that is blood-brain barrier and cell-permeable.

  • Potent and selective: ATP-competitive JNK inhibitor.
  • Activity: IC50 values are 150 nM, 220 nM, and 70 nM for hJNK1, hJNK2, and hJNK3 respectively.
  • Biological effects: Reduces cell adhesion and migration in cancer cells; exhibits neuroprotective and anti-ischemic effects in vivo.
  • Properties: Blood-brain barrier permeable and cell-permeable.
  • Purity: >95%.
  • Molecular weight: 372.4 Da.
  • Form: Solid.

The product is subject to the following: Abcam Restricted Use Statement

Specifications

Target Molecule JNK (hJNK1, hJNK2, hJNK3)
Shipping Condition Ambient
Form Solid
Alternate Part Number AS601245
Buffer 100% 2-(1,3-benzothiazol-2-yl)-2-[2-(2-pyridin-3-ylethylamino)pyrimidin-4-yl]acetonitrile
Content And Storage Store at -20°C.
Formulation 100% 2-(1,3-benzothiazol-2-yl)-2-[2-(2-pyridin-3-ylethylamino)pyrimidin-4-yl]acetonitrile
Quantity 25 mg
For Use With (Application) Cancer research, Neuroprotection, Anti-ischemic studies
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.